Biopôle and BioAlps have the pleasure to invite you to a Deep Dive with a focus on the challenges in ATMPs manufacturing on 10 October 2023 at Biopôle.
Advanced Therapy Medicinal Products (ATMPs) are medicines for human use that are based on genes, tissues or cells. They offer groundbreaking new opportunities for the treatment of disease and injury. But manufacturing them, conducting clinical trials and getting certification is a challenging journey. In this session, followed by a networking apero, experts from Swissmedic, the Centre for Experimental Therapies (CTE) of the CHUV, Lonza and NewBiologix will give their insight on the matter. After the conference, participants will have the opportunity to visit NewBiologix premises at Biopôle.
Programme
3.45 pm – Welcome of Participants
4 pm – Welcome Address
- Magali Bischof, Secretary General, BioAlps
- Pierre-Jean Wipff, Director of Innovation and Partnerships, Biopôle
4.10 pm – Presentation of the Centre for Experimental Therapies (CTE) of the CHUV with Prof. Lana Kandalaft
4.30 pm – Dr Julia Djonova, Head of Advanced Therapy Medicinal Products at Swissmedic
4.50 pm – Presentation of NewBiologix with Prof. Igor Fisch, CEO, NewBiologix
5.10 pm – Dr. Christoph Meyer, Global Head Quality Control, Cell & Gene Technologies, Lonza
5.30 pm – Visit of NewBiologix
6.00 pm – Apero
7.00 pm – End of the Deep Dive
📆 10 October 2023, 4 pm – 7 pm
📍 Salle Serine, floor -2, SERINE Building, Biopôle
▶️ Only 50 seats available, registration is free but compulsory